Lupin launches generic drug to treat Wilson's disease in US market

The Mumbai-based drug firm's product is the generic equivalent of Mylan Specialty's Depen tablets, which are indicated for the treatment of Wilson's disease, Cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kDLEEv
via IFTTT